"Myeloblastin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A polymorphonuclear leukocyte-derived serine protease that degrades proteins such as ELASTIN; FIBRONECTIN; LAMININ; VITRONECTIN; and COLLAGEN. It is named for its ability to control myeloid cell growth and differentiation.
Descriptor ID |
D053146
|
MeSH Number(s) |
D08.811.277.656.300.760.530 D08.811.277.656.959.350.530
|
Concept/Terms |
Myeloblastin- Myeloblastin
- Leukocyte Proteinase 3
- Proteinase 3, Leukocyte
- Myeloblastin, Human
- Human Myeloblastin
- N-Proteinase 4
- N Proteinase 4
- PRTN3 Gene Protein
- Protein, PRTN3 Gene
- Neutrophil Proteinase 3, Human
- Neutrophil Proteinase 4
- Proteinase 4, Neutrophil
- Proteinase 3
- Wegener Autoantigen
- Autoantigen, Wegener
- C-ANCA Antigen
- Antigen, C-ANCA
- C ANCA Antigen
- Azurophil Granule Protein 7
- Neutrophil Proteinase 3
- Proteinase 3, Neutrophil
|
Below are MeSH descriptors whose meaning is more general than "Myeloblastin".
Below are MeSH descriptors whose meaning is more specific than "Myeloblastin".
This graph shows the total number of publications written about "Myeloblastin" by people in this website by year, and whether "Myeloblastin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
1999 | 0 | 2 | 2 |
2000 | 0 | 1 | 1 |
2003 | 0 | 2 | 2 |
2004 | 0 | 1 | 1 |
2005 | 0 | 2 | 2 |
2006 | 1 | 0 | 1 |
2007 | 3 | 0 | 3 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 0 | 2 | 2 |
2012 | 2 | 0 | 2 |
2013 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2016 | 2 | 1 | 3 |
2017 | 2 | 1 | 3 |
2018 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myeloblastin" by people in Profiles.
-
Pulmonary manifestations and outcomes in paediatric ANCA-associated vasculitis: a single-centre experience. Rheumatology (Oxford). 2021 07 01; 60(7):3199-3208.
-
Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018 09 01; 201(5):1389-1399.
-
Severe destructive nasopharyngeal granulomatosis with polyangiitis with superimposed skull base Pseudomonas aeruginosa osteomyelitis. BMJ Case Rep. 2017 Jul 19; 2017.
-
Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone. Cancer Res. 2017 06 15; 77(12):3144-3150.
-
Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Arthritis Rheumatol. 2017 05; 69(5):1054-1066.
-
PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia. Cytotherapy. 2016 08; 18(8):995-1001.
-
A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells. Cytotherapy. 2016 08; 18(8):985-994.
-
Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo. Leukemia. 2016 07; 30(7):1475-84.
-
A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury. Crit Care Med. 2015 Aug; 43(8):1646-53.
-
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant. Leukemia. 2013 Jul; 27(7):1538-47.